INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 65 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,000 | -6.7% | 14,176 | 0.0% | 0.00% | – |
| Q3 2019 | $15,000 | -42.3% | 14,176 | 0.0% | 0.00% | – |
| Q2 2019 | $26,000 | -3.7% | 14,176 | 0.0% | 0.00% | – |
| Q1 2019 | $27,000 | +58.8% | 14,176 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -55.3% | 14,176 | 0.0% | 0.00% | – |
| Q3 2018 | $38,000 | +40.7% | 14,176 | 0.0% | 0.00% | – |
| Q2 2018 | $27,000 | -10.0% | 14,176 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | +3.4% | 14,176 | 0.0% | 0.00% | – |
| Q4 2017 | $29,000 | -70.4% | 14,176 | -80.8% | 0.00% | -100.0% |
| Q3 2017 | $98,000 | +28.9% | 73,916 | +51.9% | 0.00% | +100.0% |
| Q2 2017 | $76,000 | -31.5% | 48,666 | +41.1% | 0.00% | -50.0% |
| Q1 2017 | $111,000 | +136.2% | 34,490 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $47,000 | – | 34,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |